Skip to main content
logo
Noveris Health Sciences Inc. (CSE:NVRS)
Canada flag Canada · Delayed Price · Currency is CAD
0.1500
-0.0250 (-14.29%)
At close: Aug 28, 2026

Noveris Health Sciences Ratios and Metrics

Millions CAD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
9011637
Market Cap Growth
1322.10%-38.00%-41.26%-82.03%-83.98%-51.37%
Enterprise Value
77771135
Last Close Price
0.150.310.501.0022.50350.00

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
0.460.13----
PS Ratio
-----4875.24
PB Ratio
-3.90-0.03-0.04-0.09-4.56172.87
P/TBV Ratio
-----172.87
P/FCF Ratio
-40.84----
P/OCF Ratio
-40.84----

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
-----4721.86
EV/FCF Ratio
-776.46----

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-0.19-0.77-0.45-0.45-3.7321.30
Debt / FCF Ratio
-1022.29----
Net Debt / Equity Ratio
0.71-0.77-0.45-0.451.7014.23
Net Debt / EBITDA Ratio
---2.75-0.570.14-0.14
Net Debt / FCF Ratio
5.671021.26-184.20-1.280.26-0.12
Asset Turnover
-----0.00
Quick Ratio
0.470.000.000.021.260.58
Current Ratio
0.470.000.000.021.471.77
Return on Equity (ROE)
------1250.41%
Return on Assets (ROA)
-27.51%-1055.07%-1192.05%-124.30%-117.75%-163.15%
Return on Capital Employed (ROCE)
20.10%4.20%16.40%78.80%-463.90%-482.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
18.26%762.96%-514.11%-1992.40%-158.05%-79.11%
FCF Yield
-3.23%2.45%-6.04%-401.11%-144.01%-66.64%
Buyback Yield / Dilution
-297.18%-3.57%-94.24%-254.98%-84.71%-105.85%